View source for 20240033341. HIV VACCINE IMMUNOGENS simplified abstract (California Institute of Technology)

=HIV VACCINE IMMUNOGENS=


==Organization Name==

[[:Category:California Institute of Technology|California Institute of Technology]]


[[Category:California Institute of Technology]]

==Inventor(s)==

[[:Category:Harry Gristick of Pasadena CA (US)|Harry Gristick of Pasadena CA (US)]][[Category:Harry Gristick of Pasadena CA (US)]]

[[:Category:Pamela J. Bjorkman of Altadena CA (US)|Pamela J. Bjorkman of Altadena CA (US)]][[Category:Pamela J. Bjorkman of Altadena CA (US)]]

[[:Category:Harald Hartweger of New York NY (US)|Harald Hartweger of New York NY (US)]][[Category:Harald Hartweger of New York NY (US)]]

[[:Category:Michel C. Nussenzweig of New York NY (US)|Michel C. Nussenzweig of New York NY (US)]][[Category:Michel C. Nussenzweig of New York NY (US)]]

==HIV VACCINE IMMUNOGENS - A simplified explanation of the abstract==


This abstract first appeared for US patent application 20240033341 titled 'HIV VACCINE IMMUNOGENS

==Simplified Explanation==

The abstract of this patent application describes the invention of HIV immunogens and their use in generating an immune response in a subject. It also discloses a method for treating or preventing HIV infection in a subject using these HIV immunogens or antibodies generated by the disclosed methods.

* The patent application describes HIV immunogens and their use in generating an immune response in a subject.
* The disclosed method can be used for treating or preventing HIV infection in a subject.
* The invention includes the use of HIV immunogens or antibodies generated by the disclosed methods.

== Potential Applications ==
* Treatment of HIV infection: The disclosed HIV immunogens and antibodies can be used as a potential treatment for HIV infection in humans.
* Prevention of HIV infection: The disclosed method can be used to develop vaccines or immunotherapies for preventing HIV infection in individuals at risk.

== Problems Solved ==
* Lack of effective HIV treatments: The invention addresses the problem of limited treatment options for HIV infection by providing a novel approach using HIV immunogens and antibodies.
* Limited prevention strategies: The disclosed method offers a new avenue for developing preventive measures against HIV infection, which is crucial in regions with high HIV prevalence.

== Benefits ==
* Enhanced immune response: The HIV immunogens and antibodies generated by the disclosed methods can stimulate a robust immune response in individuals, potentially leading to better control of HIV infection.
* Versatile application: The disclosed method can be used in various settings, including both therapeutic and preventive approaches, providing flexibility in addressing different stages of HIV infection.


==Original Abstract Submitted==

provided herein are hiv immunogens and uses thereof for generating an immune response in a subject. this disclosure further provides a method for treating or preventing a human immunodeficiency type i (hiv-i) infection in a subject using the disclosed hiv immunogens and/or antibodies generated by any of the methods disclosed herein.



[[Category:A61K39/21]]
[[Category:A61P37/04]]